| Model Number |
40027 |
| Medical Device Problem Codes |
Calcified (1077); Device Stenosis (4066)
|
| Health Effect - Clinical Codes |
Aortic Valve Stenosis (1717); Calcium Deposits/Calcification (1758)
|
| Date of Event |
01/15/2026
|
|
Type of Reportable Event
|
Serious Injury
|
|
Additional Manufacturer Narrative
|
|
Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
| |
|
Event or Problem Description
|
|
It was reported that 3 years and 5 months post implant of this 27mm aortic bioprosthetic valve, the patient is being evaluated for a transcatheter valve-in-valve replacement.The reason for evaluation was reported as valve stenosis.It was reported that the patient was hospitalised.Evidence of calcification was in the left ventricular outflow tract (lvot) under the left coronary cusp (lcc), right coronary cusp (rcc), non coronary cusp (ncc) and in the proximal right coronary artery (rca).Subsequently on (b)(6) 2026, the patient successfully had a 29mm aortic transcatheter valve implanted valve-in-valve.No additional adverse patient effects were reported.
|
| |
|
Search Alerts/Recalls
|